The United States leads in R&D appropriations in health, with a significant year-on-year increase of 26.43% in 2023. Japan and the UK also showed notable increases, with variations of 4.0% and 10.3% respectively. Conversely, countries like Australia and Norway saw substantial decreases in their R&D expenditures, at -21.16% and -17.76%, respectively. Over the last five years, the CAGR indicates varying trends with some countries accelerating their investment while others remain stagnant or reduce their allocations.
Future trends to watch include the potential increase in R&D funding as global health issues rise, prompting more government investment. Emerging technologies and healthcare breakthroughs may also drive shifts in budget priorities. Countries with declining investments may realign their strategies to better compete on the global stage, while those increasing their spending might enhance their R&D capabilities and output.
Top countries in Government Budget Appropriations or Outlays for R&D in Health Share by Country (Million US Dollars PPP, Constant)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 52.43 | 2023 | +3.1% | +26.43% | View data |
| 2 | 2 Japan | 19.01 | 2023 | +2.9% | +4% | View data |
| 3 | 3 France | 6.3 | 2023 | +3.24% | -2.47% | View data |
| 4 | 4 Russia | 6.17 | 2023 | -0.54% | -0.27% | View data |
| 5 | 5 Italy | 5.59 | 2023 | +2.5% | +2.26% | View data |
| 6 | 6 United Kingdom | 2.4 | 2023 | -4.34% | +10.3% | View data |
| 7 | 7 Denmark | 1.01 | 2023 | +2.85% | +44.3% | View data |
| 8 | 8 Norway | 0.52 | 2023 | -2.19% | -17.76% | View data |
| 9 | 9 Portugal | 0.52 | 2023 | +2.11% | +1.25% | View data |
| 10 | 10 Hungary | 0.32 | 2023 | +2.43% | -2.92% | View data |
